StockData
Integrated BioPharma Inc logo

Integrated BioPharma Inc (INBP) stock

INBPOTCPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.18+0.00 (0.00%)

Close on Oct 19, 2026Market cap $5.59MP/E –Yield –

Integrated BioPharma total assets

Total assets on the balance sheet at the end of each period.

Integrated BioPharma's total assets was $25.34M at Jun 30, 2026. For fiscal 2026 it was $25.34M, up 1.8% from the year before. Over ten years it grew 6.2% a year on average. The highest annual figure on record is $26.21M in fiscal 2023.

Annual total assets

PeriodPeriod endValueChange
FY2026Jun 30, 2026$25.34M+1.8%
FY2025Jun 30, 2025$24.90M-5.0%
FY2024Jun 30, 2024$26.21M0.0%
FY2023Jun 30, 2023$26.21M+3.8%
FY2022Jun 30, 2022$25.25M-0.7%
FY2021Jun 30, 2021$25.44M+10.9%
FY2020Jun 30, 2020$22.94M+15.9%
FY2019Jun 30, 2019$19.79M+35.8%
FY2018Jun 30, 2018$14.57M-4.1%
FY2017Jun 30, 2017$15.20M+8.9%
FY2016Jun 30, 2016$13.95M+20.0%
FY2015Jun 30, 2015$11.62M+0.3%
FY2014Jun 30, 2014$11.58M-8.2%
FY2013Jun 30, 2013$12.61M+6.2%
FY2012Jun 30, 2012$11.88M-13.0%
FY2011Jun 30, 2011$13.65M–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026$25.34M+1.8%
Q3 FY2026CQ1 2026Mar 31, 2026$26.67M+3.9%
Q2 FY2026CQ4 2025Dec 31, 2025$23.55M-8.2%
Q1 FY2026CQ3 2025Sep 30, 2025$25.54M-2.5%
Q4 FY2025CQ2 2025Jun 30, 2025$24.90M-5.0%
Q3 FY2025CQ1 2025Mar 31, 2025$25.66M-4.8%
Q2 FY2025CQ4 2024Dec 31, 2024$25.66M-0.2%
Q1 FY2025CQ3 2024Sep 30, 2024$26.18M-1.7%
Q4 FY2024CQ2 2024Jun 30, 2024$26.21M0.0%
Q3 FY2024CQ1 2024Mar 31, 2024$26.94M+0.2%
Q2 FY2024CQ4 2023Dec 31, 2023$25.72M-1.3%
Q1 FY2024CQ3 2023Sep 30, 2023$26.64M+1.1%
Q4 FY2023CQ2 2023Jun 30, 2023$26.21M+3.8%
Q3 FY2023CQ1 2023Mar 31, 2023$26.88M-2.9%
Q2 FY2023CQ4 2022Dec 31, 2022$26.05M-3.8%
Q1 FY2023CQ3 2022Sep 30, 2022$26.36M+8.3%
Q4 FY2022CQ2 2022Jun 30, 2022$25.25M-0.7%
Q3 FY2022CQ1 2022Mar 31, 2022$27.70M+6.0%
Q2 FY2022CQ4 2021Dec 31, 2021$27.07M+7.2%
Q1 FY2022CQ3 2021Sep 30, 2021$24.34M-1.2%
Q4 FY2021CQ2 2021Jun 30, 2021$25.44M+10.9%
Q3 FY2021CQ1 2021Mar 31, 2021$26.13M+26.6%
Q2 FY2021CQ4 2020Dec 31, 2020$25.26M+26.5%
Q1 FY2021CQ3 2020Sep 30, 2020$24.63M+25.4%
Q4 FY2020CQ2 2020Jun 30, 2020$22.94M+15.9%
Q3 FY2020CQ1 2020Mar 31, 2020$20.65M-7.1%
Q2 FY2020CQ4 2019Dec 31, 2019$19.97M-11.5%
Q1 FY2020CQ3 2019Sep 30, 2019$19.64M-0.4%
Q4 FY2019CQ2 2019Jun 30, 2019$19.79M+35.8%
Q3 FY2019CQ1 2019Mar 31, 2019$22.22M+52.0%
Q2 FY2019CQ4 2018Dec 31, 2018$22.58M+44.3%
Q1 FY2019CQ3 2018Sep 30, 2018$19.72M+47.4%
Q4 FY2018CQ2 2018Jun 30, 2018$14.57M-4.1%
Q3 FY2018CQ1 2018Mar 31, 2018$14.62M+7.4%
Q2 FY2018CQ4 2017Dec 31, 2017$15.65M+4.3%
Q1 FY2018CQ3 2017Sep 30, 2017$13.38M-8.6%
Q4 FY2017CQ2 2017Jun 30, 2017$15.20M–
Q3 FY2017CQ1 2017Mar 31, 2017$13.61M–
Q2 FY2017CQ4 2016Dec 31, 2016$15.00M–
Q1 FY2017CQ3 2016Sep 30, 2016$14.65M–

More Integrated BioPharma figures

See a number that looks wrong?